These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7437263)

  • 21. Plasma and salivary pharmacokinetics of caffeine in man.
    Newton R; Broughton LJ; Lind MJ; Morrison PJ; Rogers HJ; Bradbrook ID
    Eur J Clin Pharmacol; 1981; 21(1):45-52. PubMed ID: 7333346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses.
    Ferry JJ; Horvath AM; Bekersky I; Heath EC; Ryan CF; Colburn WA
    J Clin Pharmacol; 1988 Jan; 28(1):81-7. PubMed ID: 3350994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose dependent pharmacokinetics of prednisolone.
    Pickup ME; Lowe JR; Leatham PA; Rhind VM; Wright V; Downie WW
    Eur J Clin Pharmacol; 1977 Nov; 12(3):213-9. PubMed ID: 590308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in prednisolone disposition as a result of time of administration, gender and dose.
    Meffin PJ; Brooks PM; Sallustio BC
    Br J Clin Pharmacol; 1984 Apr; 17(4):395-404. PubMed ID: 6721985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioavailability assessment of a liquid prednisone preparation.
    Georgitis JW; Flesher KA; Szefler SJ
    J Allergy Clin Immunol; 1982 Oct; 70(4):243-7. PubMed ID: 7119300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. II. PSL pharmacokinetics during intermittent treatment with PSL administration 4 consecutive days a week].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 May; 63(5):675-94. PubMed ID: 3622862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single dose of azathioprine does not affect the pharmacokinetics of prednisolone following oral prednisone.
    Frey FJ; Lozada F; Guentert T; Frey BM
    Eur J Clin Pharmacol; 1981 Feb; 19(3):209-12. PubMed ID: 7215419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetics of prednisolone (PSL) during PSL treatment. I. PSL pharmacokinetics during daily PSL treatment].
    Goshima E; Yasuda K; Fuwa Y; Adachi K; Minamori Y; Murase H; Murayama M; Yamakita N; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):697-712. PubMed ID: 3758429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of P-glycoprotein modulation on plasma concentrations and pharmacokinetics of orally administered prednisolone in dogs.
    Van der Heyden S; Croubels S; Gadeyne C; Ducatelle R; Daminet S; Murua Escobar H; Sterenczak K; Polis I; Schauvliege S; Hesta M; Chiers K
    Am J Vet Res; 2012 Jun; 73(6):900-7. PubMed ID: 22620706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone.
    Chen MF; Shimada F; Kato H; Yano S; Kanaoka M
    Endocrinol Jpn; 1991 Apr; 38(2):167-74. PubMed ID: 1752235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies comparing the metabolic clearance rate of 11 beta,17,21-trihydroxypregn-1,4-diene-3,20-dione (prednisolone) after oral 17,21-dihydroxypregn-1,4-diene-3,11,20-trione and intravenous prednisolone.
    Hsueh WA; Paz-Guevara A; Bledsoe T
    J Clin Endocrinol Metab; 1979 May; 48(5):748-52. PubMed ID: 429520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inequality of clearance values obtained by intravenous bolus and by steady-state infusion. Prednisolone studies in dogs.
    Frey FJ; Frey BM
    Pharmacology; 1982; 24(6):346-54. PubMed ID: 7111375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
    Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.